Tel Aviv, Israel

Alcobra Ltd.

Calculating rank
USPTO Granted Patents = 8

% Expired Patents = 75.0


Forward Citations = 15

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Dalia Megiddo (6 out of 16 patents)

silverMedal Rina Yamin (5 out of 6 patents)

bronzeMedal Yaron Ilan (3 out of 47 patents)

4.  Yaron Daniely (3 out of 5 patents)

5.  Shimon Amselem (2 out of 38 patents)

6.  Gur Megiddo (2 out of 2 patents)

7.  David Baker (1 out of 4 patents)

8.  Hanna Ron (1 out of 3 patents)

9.  David Siner (1 out of 3 patents)

10.  Jonathan Rubin (1 out of 1 patent)

11.  Johanna Schumann (1 out of 1 patent)


8 patents:

Company Overview
Alcobra Ltd. is a biopharmaceutical company focused on the development and commercialization of novel treatments for central nervous system disorders. Their lead product candidate, MDX, is currently in clinical trials for the treatment of Fragile X Syndrome and ADHD. Alcobra is dedicated to improving the lives of patients through innovative therapies and research.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Alcobra Ltd. USPTO Patent Assignee Logo
8 Patents

#156 in Tel Aviv

#797 in Israel

Tel Aviv, IL
Tel Aviv, Israel
Forward Citations = 15

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alcobra Ltd.. Retrieved from https://idiyas.com/company/alcobra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…